ReviewChemical & biomedical imaging2023
Recent Advances in Enhancement of Raman Scattering Intensity for Biological Applications.
Review in Chemical & biomedical imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Research on a rapid and accurate diagnosis platform for liver fibrosis based on machine learning-assisted SERS technology.Biomedical optics express · 2026Article
- Mitochondria-Targeted Au@Carbon Dot Nanoprobes for SERS Analysis of Drug-Induced Mitophagy.Chemical & biomedical imaging · 2026Article
- Probing Heterogeneous Catalytic Reactions via Tip-Enhanced Raman Spectroscopy: Recent Progress and Future Perspectives.Chemical & biomedical imaging · 2026Review
- Surface-Enhanced Raman Scattering Imaging of Dynamic pH Changes in Lysosomes during Cancer Cell Invasion on a Microfluidic Chip.Chemical & biomedical imaging · 2026Article
- Stimulated Raman Scattering Imaging Enabled Biomarker Discovery for Precision Medicine.Chemical & biomedical imaging · 2025Review
- Confocal Raman microspectroscopy for spatially resolved tissue characterisation of disease-linked spectra-pathological signatures.Clinical and translational medicine · 2025Review
- Unveiling the Invisible: Multiscale Molecular Insights through Raman Imaging.Chemical & biomedical imaging · 2025Article
- Recent progress on nanotechnologies for enhancing blood-brain barrier permeability.Smart molecules : open access · 2025Review
- Rapid diagnosis of bacterial vaginosis using machine-learning-assisted surface-enhanced Raman spectroscopy of human vaginal fluids.mSystems · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Raman scattering spectroscopy has attracted great interest for its significant potential in multiplexed biological imaging and sensing. However, the extremely weak molecular Raman scattering signal raises considerable concerns about its applicability in physiological conditions. Many multidisciplinary attempts, combining optics, materials science, and biology, have been conducted in the past decades to solve the problem of insufficient Raman scattering intensity and to realize the practical application of Raman scattering technology in the field of life science. In addition, to overcome the bottleneck of a single enhancement technology, more and more emphasis has been given to the combination of multiple Raman enhancement technologies. The underlying ideas behind each enhancement mechanism needs to be fully comprehended to effectively combine various techniques for desired signal intensity. Here, we summarize recent strategies developed for the enhancement of the signal strength of Raman scattering. We will also analyze the major advantages and disadvantages of each enhancement technique and provide perspectives for the compatibility and complementarity among different enhancement mechanisms.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.